Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism.

Cite this paper

@article{Briand2016EmpagliflozinVS, title={Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism.}, author={François Xavier Briand and Eric Mayoux and Emmanuel Brousseau and No{\'e}mie Burr and Isabelle Urbain and Cl{\'e}ment Costard and Michael P. Mark and Thierry Sulpice}, journal={Diabetes}, year={2016}, volume={65 7}, pages={2032-8} }